Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Kelly Brantley
Vice PresidentAvalere Health
Health Policy OutlookAvalere Health | An Inovalon CompanyFebruary 8, 2018
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
3
Agenda
2017 Recap1
2
3
4
5
The Tax Cut and Jobs Act
Individual Market Outlook
Medicaid Waiver Reforms
Copay Optimization Programs
Midterm Elections Outlook 6
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
TIMELINE OF KEY 2017 REPEAL AND REPLACE ACTIVITIES
Senate Passes Resolution to Repeal the ACA Through Budget Reconciliation
Trump Signs Executive Order on ACA Enforcement
Jan 20Jan 4 May 4
ACA: Affordable Care Act; AHCA: American Health Care Act; BCRA: Better Care Reconciliation Act; HCFA: Health Care Freedom Act; ORRA: Obamacare Repeal Reconciliation Act; GCHJ: Graham Cassidy Heller Johnson ACA repeal bill; HHS: U.S. Department of Health and Human Services
AHCA Passes 217-213
BCRA Fails 43-57
July 26-28
ORRA Fails 45-55
HCFA Fails 49-51
Oct 18
Alexander- Murray Release Market Stabilization Package
Senate Pulls GCHJ Ahead of Potential Vote
Sept 20Aug 31
HHS Announces 90% Cut to 2018 Federal Navigator Funding
White House Announces End to Federal CSR Payments
Oct 13
Last Day to Pass ACA Repeal & Replace Under Reconciliation
Oct 12
Sept 30 Nov 1
Repeal and Replace Efforts Consumed the 2017 Congressional Agenda
Shortened OEP Begins
Trump Signs Executive Order on Healthcare Choice and Competition
Executive Action
House Action
Senate Action
Deadlines
Signed into Law
Individual Mandate Repealed
4
Dec 22
2017 Recap
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
Individual Mandate
Medical Expense Deduction
Orphan Drug Tax Credit
Charitable Giving
5
The Tax Cut and Jobs Act of 2017 Will Affect theHealthcare of Patients via Several Mechanisms
After December 31, 2018, the ACA’s individual mandate is repealed.
In 2017 and 2018, medical expenses exceeding 7.5% of an individual’s adjusted gross income are tax deductible. Beginning in 2019, the threshold increases to 10%.
As of January 1, 2018, the Orphan Drug tax credit for developers of rare disease drugs was reduced from 50% to 25% of qualified clinical trial costs.
As of January 1, 2018, the percentage limit for charitable cash donations by an individual taxpayer to public charities and certain other organizations increased from 50% to 60%.
H.R. 1, The Tax Cut and Jobs Act. December 18, 2017. Available at: http://docs.house.gov/billsthisweek/20171218/CRPT-115HRPT-466.pdf
Tax Reform
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
6
CBO Indicates Repeal of the Individual MandateWill Lower Deficits and Increase Uninsurance
Premiums and Stability /
$338 Billion 4 millionIncrease in Number of Uninsured by 2019
Reduction in Federal Deficits
13 MillionIncrease in Number of Uninsured by 2027
CBO. Repealing the Individual Health Insurance Mandate: An Updated Estimate. November 2017.
Individual Market
CBO estimated the nongroup market would remain stable over the next 10 years, but premiums would increase by about 10 percent “in most years of the decade.”
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
0.61.5
2.3 2.83.6
4.7
8.7
1
9.69.2
0
1
2
3
4
5
6
7
8
9
10
0 10 20 30 40 50 60 70 80 90 100
Tota
l Enr
ollm
ent (
Mill
ions
)
Percent of OEP Elapsed
2018 (Current) 2016 2017
Exchange Enrollment Rates Declined for 2018, Due in Part to Shortened Open Enrollment Period
7
HealthCare.gov Sign-Ups During Open Enrollment, Includes Auto-Reenrollment*
*2016 and 2017 enrollment figures include auto-reenrollment effective December 15.Note: 2018 OEP for the FFE ended on December 15, 2017. Sources: Avalere analyzed HHS’ publicly available biweekly enrollment reports published for the 2016, 2017, and 2018 OEPs.
Individual Market
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
8
Over Half of Counties Will Have A Single Issuer, a Substantial Jump from 2017
35%
56%
33%
27%
32%17%
2017 2018
Perc
ent o
f Cou
ntie
s
3+ Issuers
2 Issuers
1 Issuer
ISSUER PARTICIPATION BY COUNTY IN FFE STATES, 2017-2018
FFE: Federally Facilitated ExchangeSource: Avalere PlanScape®, a proprietary analysis of exchange plan features, November 2017. Avalere analyzed data from the FFE Individual Landscape File released October 2017.
Individual Market
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
AHP Proposed Rule Is Administration’s First Step to Introduce New Insurance Options in the Market
9ACA: Affordable Care Act; AHP: Association Health Plan; DOL: Department of Labor; EO: Executive Order; HIPAA: Health Insurance Portability and Accountability Act; Department of Labor. “Definition of “Employer” under Section 3(5) of ERISA -- Association Health Plans.”
Proposed AHP Changes
AHP Eligibility • Ensures sole proprietors who are actively engaged in a legitimate trade or business have access to AHP coverage
AHP “Large Group” Status
• Requires AHP members to either: 1) be in the same trade, industry, line of business, or profession or 2) have a principal place of business in same state or metro area (even if crosses state lines)
Anti-Discrimination
• Prohibits exclusion of any employee or group, prohibits premiums based on health risk, and applies nondiscrimination provisions of the ACA and HIPAA
• On January 4, the DOL issued a proposed rule to expand access to AHPs and make it easier for AHPs to avoid some state and federal coverage and benefit mandates
Individual Market
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
While Entitlement Reform Is Unlikely in 2018, Changes to Medicaid Will Occur via Waiver Activity
EligibilityReduce expansion eligibility
EnrollmentTime limits
Lockout periods
Program IncentivesWork requirements
Wellness programs
Cost SharingHigher premiums / cost sharing
Drug CoverageExclude / cover fewer drugs
Plan DesignAlter benefit package
Restrict networks
10
Medicaid Waivers
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
The Trump Administration Is Reconsidering
Flexibilities Previously Denied
11FPL: Federal Poverty Level
Note: Mississippi’s waiver has not been submitted to CMS yet. The state intended to submit in December.
Category Waiver Component Denied Pending Approved
Eligibility Reduce expansion eligibility to 100%
FPL; maintain enhanced match – AR, MA
Enrollment
Indefinite disenrollment until all
Medicaid debts are paidOH WI
Time limits on Medicaid enrollment
(e.g., 4-5 years)– AZ, UT, WI, KS, ME
Work Requirement
Work requirement as a condition of
eligibilityNH, PA AR, AZ, KS, ME, MS, NC,
NH, UT, WI KY, IN
Premiums / Cost Sharing
Premiums may be greater than 2% of
incomeIN IN
Mandatory premiums for individuals
with incomes <100% FPL OH ME, NC, WI KY
Total cost sharing up to 7% of income MI –
Prescription Drug
Coverage
Closed formulary; exclude drugs with
inadequate evidence of clinical efficacy– MA, AZ
Medicaid
Waivers
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
12
State Waiver Changes May Reduce Access butOffers Opportunities to Engage with States
• Greater required cost sharing
• Higher premiums• Health savings
accounts (HSAs)
• Decreased eligibility• Work requirements• Lockout periods /
disenrollment
• Allow coverage of fewer drugs
• More strict use of utilization management
Lower Enrollment
Patient Affordability
Less Generous Drug Coverage
Decreased Patient Access
Opportunity for State-Level
Engagement
KEY WAIVER IMPLICATIONS PATIENT COMMUNITY CONSIDERATIONS
Medicaid Waivers
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
Copay Optimization Programs Limit the Effect of Manufacturer Copay Assistance
13
Manufacturer copay assistance has traditionally applied towards a member’s deductible and/or OOP maximums
To limit their payer/employer customers’ liability for costs above a member’s deductible/OOP maximum, PBMs increasingly are implementing Copay Optimization Programs
Model A (More Common): Accumulator Adjustment Program● PBMs will track copay assistance
and adjust the accumulator (deductible and OOP max) to apply the amount the member (versus the third party) is paying OOP
Model B: Maximum Copay Allowance Program● PBMs will adjust a member’s copay
for select specialty drugs up to the maximum manufacturer copay allowance
OOP: Out-of-Pocket costs are expenses not reimbursed by insurer and can include deductibles, coinsurance, and copayments
As Copay Optimization Programs are expected to grow in 2018, the patient community will need to develop a strategic approach to address and counteract their impact.
Copay Assistance
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
Early Legislative Deadlines and NovemberElections Will Likely Shape 2018 Environment
14CHIP: Children’s Health Insurance Program; VBC: Value Based Contracting
*Expected to pass by midnight on February 8
TIMELINE OF 2017/2018 KEY DATES AND EVENTS
Dec 20: Congress Passes Tax
Reform
Dec 15: 2018 Exchange
Open Enrollment
Period Ends
Dec 21: Congress Passes Stop-gap Government
Funding PackageJan 16: Comments
Due on Medicare Part C/D Proposed Rule
Jan 22: Congress Passes Stop-gap Government Funding
Package with 6-yearCHIP Reauthorization
Early Feb: President’s FY2019 Budget
Request
Early March: Expected Debt
Limit
Jan 29: Alex Azar Sworn in as HHS
Secretary
Mid/Late 2018: Potential Action on Market Stabilization
Mid/Late 2018: Potential Administrative Action on VBC, Pass Through Rebates
Nov 6: Midterm Elections
Nov 1: 2019 Exchange Open Enrollment
Period Begins
Exchange Market Activity
Administrative Activity
Legislative Deadline / Action
Feb 7: Senate Unveils 2-Year Budget
Agreement* March:
Expected Omnibus Bill
Midterm Outlook
Copyright Ó2017. Avalere Health LLC. All Rights Reserved.
The 2018 Midterm Elections Will Dictate Future Activity on Numerous Healthcare Policies
15
Status QuoRepublicans retain control of Congress
• Renewed efforts to repeal/replace the ACA
• Potential movement on entitlement reform
Partially Divided GovernmentDemocrats control one of the two houses of Congress
• No legislative options for repeal/replace activities
• Current Congressional oversight efforts curtailed
Divided GovernmentDemocrats sweep both houses of Congress
• Congress broadly changes priorities on healthcare policy
• Opportunity to compromise in certain areas (e.g., drug pricing)
Down Ballot Changes: State-level election results could influence current activity on drug pricing policies and Medicaid waivers.
Midterm Outlook